Erasca, Inc. (ERAS) Misses Q2 EPS by 3c

Erasca, Inc. (NASDAQ: ERAS) reported Q2 EPS of ($0.14), $0.03 worse than the analyst estimate of ($0.11).

For earnings history and earnings-related data on Erasca, Inc. (ERAS) click here.

You May Also Be Interested In

• Attention Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY); Bloom Energy Corporation (NYSE: BE); Erasca, Inc. (NASDAQ: ERAS); and Insulet Corporation (NASDAQ: PODD): Grabar Law Offic
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c